Financial comparisons Orthocell Limited
Equities
OCC
AU000000OCC6
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9100 AUD | -4.21% |
|
-1.09% | -16.13% |
| 02/02 | Orthocell Eyes Fiscal 2027 Entry Into UK, European Union Markets | MT |
| 19/01 | Orthocell posts quarterly revenue of A$3.2 million | RE |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 4.29TCr | 14.77% | 22.64% | 17.4% | 8.55% | 2.51x | ||
| 1.01TCr | 28.38% | 37.36% | 16.57% | 14.57% | -1.17x | ||
| 2.39TCr | 16.33% | 28.89% | 7.57% | 4.81% | 1.93x | ||
| 1.67TCr | 11.06% | 27.04% | 18.15% | 10% | 2.14x | ||
| 2.74TCr | 9.17% | 16.49% | 14.77% | 5.92% | 2.84x | ||
| 543.95Cr | 76.75% | 27.84% | 17.48% | 12.98% | -2.02x | ||
| 514.63Cr | 27.22% | 34.26% | 25.97% | 18.7% | -0.29x | ||
| 2.06TCr | 10.1% | 15.3% | 22.14% | 5.95% | 1.47x | ||
| 694.8Cr | 18.75% | 25.66% | 25.19% | 12.96% | 0.8x | ||
| 503.15Cr | 31.77% | 35.7% | 32.58% | 22.31% | -1.13x | ||
| 1.87TCr | -3.9% | 11.53% | 10.82% | -2.4% | 1.76x | ||
| 295.84Cr | 21.56% | 30.97% | 42.82% | 13.9% | 1.17x | ||
| 437.2Cr | -27.97% | 13.27% | 9.61% | 4.75% | 0.95x | ||
| 410.05Cr | 13.8% | 30.18% | 19.07% | 10.68% | 0.23x | ||
| 666.01Cr | 11.82% | 16.29% | 15.6% | 10.72% | -0.1x | ||
| 275.59Cr | 9.81% | 28.28% | 7.75% | 4.64% | 2.34x | ||
| 336.64Cr | 3.36% | 15.39% | 22.59% | 7.17% | 3.17x | ||
| Average | 1.22TCr | 16.05% | 24.54% | 19.18% | 9.78% | 0.98x | |
| Weighted average by Cap. | 1.99TCr | 19.14% | 27.02% | 17.17% | 9.91% | 1.08x |
- Stock Market
- Equities
- OCC Stock
- Sector Orthocell Limited
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















